| Description | Cytidoline sodium salt is an intermediate in the synthesis of phosphatidylcholine which is a component of cell membranes and also exerts neuroprotective effects. |
|---|
| Related Catalog | Signaling Pathways >> Others >> Others Research Areas >> Neurological Disease |
|---|
| Solvent | In Vitro: H2O : 300 mg/mL (586.73 mM; Need ultrasonic and warming) |
|---|
| Solubility | 1 mM1.9558 mL9.7788 mL19.5576 mL5 mM0.3912 mL1.9558 mL3.9115 mL10 mM0.1956 mL0.9779 mL1.9558 mL |
|---|
| Storage | Powder-20°C3 years 4°C2 yearsIn solvent-80°C6 months -20°C1 month |
|---|
| Shipping | Room temperature in continental US; may vary elsewhere |
|---|
| SMILES | O[C@H]1[C@H](N(C=CC(N)=N2)C2=O)O[C@H](COP(OP(OCC[N+](C)(C)C)([O-])=O)(O)=O)[C@H]1O.[Na] |
|---|
| References | [1]. Davinelli S, et al. Cytoprotective Effects of Citicoline and Homotaurine against Glutamate and High Glucose Neurotoxicity in Primary Cultured Retinal Cells. Oxid Med Cell Longev. 2017;2017:2825703. [2]. Karpova MN, et al. Increase of the seizure threshold in C57BL/6 mice after citicoline administration. Bull Exp Biol Med. 2015 Jan;158(3):315-7. |
|---|
| Related Molecules | Captisol | Cyclosporin A | H2DCFDA | 0MPTP hydrochloride | GW4869 | Etomoxir | TD139 | Mitoquinone mesylate | GSK2795039 | JC-1 | BAPTA-AM | AP 20187 | Setanaxib (GKT137831) | D-Luciferin | Monocrotaline |
|---|
China
